Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Taupin

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Human Gene Therapy|February 1, 2019
Innovative Curative Treatment of Beta Thalassemia: Cost-Efficacy Analysis of Gene Therapy Versus Allogenic Hematopoietic Stem-Cell TransplantationSéverine Coquerelle, Mariem Ghardallou, Setti Rais, et al.
Blood|February 7, 2012
Transplantation in patients with SCID: mismatched related stem cells or unrelated cord blood?Juliana F Fernandes, Vanderson Rocha, Myriam Labopin, et al.
The Journal of Allergy and Clinical Immunology|August 3, 2010
Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better?Andrew R Gennery, Mary A Slatter, Laure Grandin, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Human Gene Therapy|February 1, 2019
Innovative Curative Treatment of Beta Thalassemia: Cost-Efficacy Analysis of Gene Therapy Versus Allogenic Hematopoietic Stem-Cell TransplantationSéverine Coquerelle, Mariem Ghardallou, Setti Rais, et al.
Blood|February 7, 2012
Transplantation in patients with SCID: mismatched related stem cells or unrelated cord blood?Juliana F Fernandes, Vanderson Rocha, Myriam Labopin, et al.
The Journal of Allergy and Clinical Immunology|August 3, 2010
Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better?Andrew R Gennery, Mary A Slatter, Laure Grandin, et al.
Pageof 3